Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.W | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Post by Claridgeon Dec 09, 2019 10:29pm
105 Views
Post# 30438173

World Bladder Cancer Patient Coalition (BCC+BCAN+UK Bladder)

World Bladder Cancer Patient Coalition (BCC+BCAN+UK Bladder)That was the link that I posted months ago.

Don't worry.  The word will spread quite rapidly among the patients community, once we have solid data on a statistically significant pool of patients.  Timing couldn't be better to spark a fire and spread the news at speed of light.




18 March, 2019

New global bladder cancer patient organization launches

For the first time ever, people affected by bladder cancer – the 10th most common cancer in the world, with more than half-a-million new cases reported every year – will have a global voice.

BARCELONA, 18 March, 2019 – The World Bladder Cancer Patient Coalition (WBCPC) officially launched today at the European Association of Urology congress in Barcelona, Spain.

The need is critical. Bladder cancer is the 10th most common cancer in the world, with more than half-a-million new cases reported every year.1

Three major bladder cancer organisations, The Bladder Cancer Advocacy Network (US), Fight Bladder Cancer (UK) and Bladder Cancer Canada worked together to found the organization.

“Treatment, research and support for bladder cancer patients varies widely across the globe and even within countries,” said Ken Bagshaw, the current President of the World Bladder Cancer Patient Coalition. “It’s critical that we mobilize bladder cancer patient organizations across the world to help ensure the best possible outcomes for patients.”

“The World Bladder Cancer Patient Coalition unites patients around the world giving them a powerful voice in the fight against a lethal disease that significantly impacts not only their survival but also their quality of life,” adds Piyush Agarwal, of the Center for Cancer Research, (U.S.) National Cancer Institute. “The World Bladder Cancer Patient Coalition aims to create a global voice that hopes to alleviate much of the pain and suffering associated with bladder cancer.”

The mission of the World Bladder Cancer Patient Coalition is to:
• Foster an international community of people affected by bladder cancer
• Advocate for access to the best possible bladder cancer information, support, and care
• Build alliances with health professionals, policy makers, academics, researchers, and industry

The World Bladder Cancer Patient Coalition is governed by a board of directors, composed of people diagnosed with bladder cancer, carers of bladder cancer patients and those engaged with bladder cancer organizations at the national level.

The World Bladder Cancer Patient Coalition was officially launched at the European Association of Urology Congress #EAU19 in Barcelona Spain on Monday 18 March 2019 at 16:00.

CONTACTS
Ken Bagshaw, +1-905-269-4728, kenb@bladdercancercanada.org
Lydia Makaroff, +44 7427 547783, lydia@fightbladdercancer.co.uk
Andrea Maddox-Smith +1-301-215-9099 amsmith@bcan.org





Bullboard Posts